A Post Market Study to Assess the Spinal Modulation Neurostimulator System for Chronic Intractable Pain

NCT02335502 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2019-02-04

Study results available
· View outcomes & findings →

Summary

04-SMI-2012 is post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of chronic, intractable pain.

Conditions

Interventions

DEVICE

Implantation with the commercially available Axium neurostimulator

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2015-06-30
Completion
2015-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335502 on ClinicalTrials.gov